Bibliography
- Oliver SG , WinsonMK, KellDB, Baganz F: Systematic functional analysis of the yeast genome. Trends Biotechnol.16 , 373–378 (1998).
- Oliver SG : From genomes to systems: the path with yeast.Philos. Trans. R. Soc. Lond., B, Biol. Sci.361(1467) , 477–482 (2006).
- Bino RJ , HallRD, FiehnO et al.: Potential of metabolomics as a functional genomics tool. Trends Plant Sci.9(9) , 418–425 (2004).
- Nicholson JK , LindonJC, HolmesE: Metabonomics.Xenobiotica29(11) , 1181–1189 (1998).
- Nicholson JK , HolmesE, WilsonID: Gut microorganisms, mammalian metabolism and personalized health care.Nat. Rev. Microbiol.3(5) , 431–438 (2005).
- Raamsdonk LM , TeusinkB, BroadhurstD et al.: A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol.19 , 45–50 (2001).
- Allen J , DaveyHM, BroadhurstD et al.: High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol.21 , 692–696 (2003).
- Fiehn O , KopkaJ, DormannP, AltmannT, TretheweyRN, WillmitzerL: Metabolite profiling for plant functional genomics.Nat. Biotechnol.18 , 1157–1161 (2000).
- Jones GL , SangE, GoddardC et al.: A functional analysis of mouse models of cardiac disease through metabolic profiling. J. Biol. Chem.280(9) , 7530–7539 (2005).
- Ismail AA , GillGV: The epidemiology of Type 2 diabetes and its current measurement.Baillieres Best Pract. Res. Clin. Endocrinol. Metab.3(2) , 197–220 (1999).
- Kopelman PG : Obesity as a medical problem.Nature404 , 635–643 (2000).
- Brown SC , KruppaG, DasseuxJL: Metabolomics applications of FT-ICR mass spectrometry.Mass Spectrom. Rev.24(2) , 223–231 (2005).
- Griffin JL , ShockcorJP: Metabolic profiles of cancer cells.Nat. Rev. Cancer4(7) , 551–561 (2004).
- Beckwith-Hall BM , NicholsonJK, Nicholls AW et al: Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol.11 , 260–272 (1998).
- Holmes E , NichollsAW, LindonJC et al: Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed.11(4–5) , 235–244 (1998).
- Mortishire-Smith RJ , SkilesGL, Lawrence JW et al.: Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol.17(2) , 165–173 (2004).
- Griffin JL , SangE, EvensT, DaviesK, ClarkeK: Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.FEBS Letts.530(1–3) , 109–116 (2002).
- Griffin JL , NichollsAW, KeunHC, Mortishire-SmithRJ, NicholsonJK, Kuehn T: Metabolic profiling of rodent biological fluids via 1H NMR spectroscopy using a 1mm Microlitre probe. Analyst127(5) , 582–584 (2002).
- Khandelwal P , BeyerCE, LinQ, Schechter LE, Bach AC: 2nd. Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approach. Anal. Chem.76(14) , 4123–4127 (2004).
- Keun HC , BeckonertO, GriffinJL et al.: Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem.74 , 4588–4593 (2002).
- Bailey NJ , OvenM, HolmesE, Nicholson JK, Zenk MH: Metabolomic analysis of the consequences of cadmium exposure in Silene cucubalus cell cultures via 1H NMR spectroscopy and chemometrics. Phytochemistry62 , 851–858 (2003).
- Bailey NJ , SampsonJ, HylandsPJ, NicholsonJK, HolmesE: Multi- component metabolic classification of commercial feverfew preparations via high-field 1H-NMR spectroscopy and chemometrics.Planta Med.68 , 734–738 (2002).
- Vaidyanathan S , GaskellS, GoodacreR: Matrix-suppressed laser desorption/ionisation mass spectrometry and its suitability for metabolome analyses.Rapid Commun. Mass Spectrom.20(8) , 1192–1198 (2006).
- Schwudke D , OegemaJ, BurtonL et al.: Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal. Chem.78 , 585–595 (2006).
- Shellie RA , WelthagenW, ZrostlikovaJ et al.: Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J. Chromatogr. A.1086(1) , 83–90 (2005).
- Gullberg J , JonssonP, NordstromA, SjostromM, MoritzT: Design of experiments: an efficient strategy to identify factors influencing extraction and derivatization of Arabidopsis thaliana samples in metabolomic studies with gas chromatography/mass spectrometry.Anal. Biochem.331 , 283–295 (2004).
- A J , TryggJ, GullbergJ et al.: Extraction and GC/MS Analysis of the human blood plasma metabolome Anal. Chem.77 , 8086–8094 (2005).
- Plumb RS , GrangerJH, StumpfCL et al.: Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers.9(2) , 156–179 (2004).
- Valafar F : Pattern recognition techniques in microarray data analysis: a survey.Ann. NY Acad. Sci.980 , 41–64 (2002).
- Lindon JC , KeunHC, EbbelsTM, Pearce JM, Holmes E, Nicholson JK: The Consortium for Metabonomic Toxicology (COMET), aims, activities and achievements. Pharmacogenomics6(7) , 691–699 (2005).
- Holmes E , AnttiH: Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra.Analyst127(12) , 1549–1557 (2002).
- Foxall PJ , BewleyS, NeildGH, RodeckCH, NicholsonJK: Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy.Arch. Dis. Child. Fetal Neonatal Ed.73(3) , F153–F157 (1995).
- Ghauri FY , ParkesHG, NicholsonJK, WilsonID, BrentonDP: Asymptomatic 5-oxoprolinuria detected by proton magnetic resonance spectroscopyClin. Chem.39(6) , 1341 (1993).
- Holmes E , NichollsAW, LindonJC et al.: Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol.13(6) , 471–478 (2000).
- Nicholls AW , HolmesE, LindonJC et al: Metabonomic investigations into hydrazine toxicity in the rat: induction of 2-aminoacidipic acid. Chem. Res. Toxicol.14(8) , 975–987 (2001).
- Connor SC , WuW, SweatmanBC et al.: Effects of feeding and body weight loss on the 1H-NMR based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers9(2) , 156–179 (2004).
- Gavaghan McKee CL , WilsonID, NicholsonJK: Metabolic phenotyping of nude and normal (Alpk:ApfCD, C57BL10J) mice.J. Proteome Res.5 , 378–384 (2006).
- Stanley EG , BaileyNJC, BollardME et al.: Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics. Anal. Biochem.343 , 195–202 (2005).
- Phipps AN , StewartJ, WrightB, WilsonID: Effect of diet of the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity.Xenobiotica28 , 527–537 (1998).
- Robosky LC , WellsDF, EgnashLA, ManningML, ReilyMD, RobertsonDG: Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats.Toxicol. Sci.87(1) , 1–2 (2005).
- Nicholls AW , Mortishire-SmithRJ, NicholsonJK: NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats.Chem. Res. Toxicol.16(11) , 1395–404 (2003).
- Stanley EG : 1H NMR spectroscopic and chemometric studies on endogenous physiological variation in rats. PhD Thesis, University of London, UK (2002).
- Bollard ME , HolmesE, LindonJC et al.: Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high resolution 1H NMR spectroscopy of urine and pattern recognition. Anal. Biochem.295 , 194–202 (2001).
- Lenz EM , BrightJ, WilsonID, MorganSR, NashAFP: A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects.J. Pharm. Biomed. Anal.33 , 1103–1115 (2003).
- Lenz EM , Bright,J, WilsonID et al: Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal.36 , 841–849 (2004).
- Kochhar S , JacobsDM, Ramadan,Z, BerruexF, FuerholzA, FayLB: Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics.Anal. Biochem.352 , 274–281 (2006).
- Clayton TA , LindonJC, CloarecO et al.: Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature440(7087) , 1073–1077 (2006).
- Haselden JN , NichollsAW: Personalized medicine progresses.Nat. Med.12(5) , 510–511 (2006).
- Serkova NJ , JackmanM, BrownJL et al.: Metabolic profiling of livers and blood from obese Zucker rats. J. Hepatol.44 , 956–962 (2006).
- Williams RE , LenzEM, EvansJA et al.: A combined 1H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. J. Pharm. Biomed. Anal.38(3) , 465–471 (2005).
- Plumb RS , GrangerJH, StumpfCL et al.: A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst130(6) , 844–849 (2005).
- Han X , YangJ, ChengH, YangK, AbendscheinDR, GrossRW: Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction.Biochemistry44(50) , 16684–16694 (2005).
- Ringeissen , S, Connor, SC, Brown HR et al.: Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography. Biomarkers8(3–4) , 240–271 (2003).
- Xu J , ChangV, JosephSB et al.: Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux. Endocrinology145(3) , 1087–1095 (2004).
- Xu J , XiaoG, TrujilloC et al.: Peroxisome proliferator-activated receptor α (PPARα) influences substrate utilization for hepatic glucose production. J. Biol. Chem.277(52) , 50237–50244 (2002).
- Watkins SM , ReifsnyderPR, PanHJ, GermanJB, LeiterEH: Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone.J. Lipid Res.43(11) , 1809–1817 (2002).
- Su X , HanX, YangJ et al.: Sequential ordered fatty acid alpha oxidation and δ9 desaturation are major determinants of lipid storage and utilization in differentiating adipocytes. Biochemistry43(17) , 5033–5044 (2004).
- Corthesy-Theulaz I , den Dunnen JT, Ferre P et al.: The impact of biomics technology on nutrition research. Ann. Nutr. Metab.49 , 355–365 (2005).
- Whitfield PD , GermanAJ, Noble P-JM: Metabolomics: an emerging post-genomic tool for nutrition. Br. J. Nutr.92 , 549–555 (2004).
- Wang C , KongH, GuariY et al.: Plasma phospholipid metabolic profiling and biomarkers of Type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal. Chem.77(13) , 4108–4116 (2005).
- Yang J : Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.813(1–2) , 53–58 (2004).
- Clish CB , DavidovE, OresicM et al.: Integrative biological analysis of the APOE*3-leiden transgenic mouse.OMICS8 , 3–15 (2004).
- Mayr M , Chung Y-L, Mayr U et al.: Proteomic and metabolomic analysis of atherosclerotic vessels from Apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress and energy metabolism. Arteriosclerosis, thrombosis and vascular biology. 25 , 2135–2142 (2006).
- Brindle JT , AnttiH, HolmesE et al.: Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med.8(12) , 1439–1444 (2002).
- Kirschenlohr HL , GriffinJL, ClarkeSC et al.: Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat. Med.12 , 705–10 (2006).
- Sabatine MS , EmersonL, MorrowDA et al.: Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation112 , 3868–3875 (2005).
- Griffin JL , BonneySA, MannC et al.: An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics17(2) , 140–149 (2004).
Websites
- Human Metabolome Project: Human Metabolome Database. www.hmdb.ca
- The Human Serum Metabolome in Health and Disease Project. www.metabolomics.co.uk